Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis
Open Access
- 18 July 2024
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 31 (10) , e16387
Abstract
Background: Multiple sclerosis (MS) is a demyelinating disease affecting millions of people worldwide. Hereditary susceptibility and environmental factors contribute to disease risk. Infection with Epstein–Barr virus (EBV) and human herpesvirus 6A (HHV‐6A) have previously been associated with MS risk. Other neurotropic viruses, such as rubella virus (RV), are possible candidates in MS aetiopathogenesis, but previous results are limited and conflicting.Methods: In this nested case–control study of biobank samples in a Swedish cohort, we analysed the serological response towards RV before the clinical onset of MS with a bead‐based multiplex assay in subjects vaccinated and unvaccinated towards RV. The association between RV seropositivity and MS risk was analysed with conditional logistic regression.Results: Seropositivity towards RV was associated with an increased risk of MS for unvaccinated subjects, even when adjusting for plausible confounders including EBV, HHV‐6A, cytomegalovirus and vitamin D (adjusted odds ratio [AOR] = 4.0, 95% confidence interval [CI] 1.8–8.8). Cases also had stronger antibody reactivity towards rubella than controls, which was not seen for other neurotropic viruses such as herpes simplex or varicella zoster. Furthermore, we observed an association between RV seropositivity and MS in vaccinated subjects. However, this association was not significant when adjusting for the aforementioned confounders (AOR = 1.7, 95% CI 1.0–2.9).Conclusions: To our knowledge, these are the first reported associations between early RV seropositivity and later MS development. This suggests a broadening of the virus hypothesis in MS aetiology, where molecular mimicry between rubella epitopes and human central nervous system molecules could be an attractive possible mechanism.Keywords
Funding Information
- Forskningsrådet för hälsa, arbetsliv och välfärd (2015‐00195, 2017‐00687)
- Hjärnfonden (FO2020‐0077)
- Vetenskapsrådet (2015‐02419, 2016‐02349, 2020‐01998, 521‐2012‐2917)
This publication has 47 references indexed in Scilit:
- Myelin oligodendrocyte glycoprotein revisited—sensitive detection of MOG-specific T-cells in multiple sclerosisJournal of Autoimmunity, 2019
- Multiple sclerosis2018
- Rehabilitation for people with multiple sclerosis: an overview of Cochrane systematic reviewsCochrane Database of Systematic Reviews, 2017
- The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literatureJournal of Neurology, 2016
- The immunogenetics of multiple sclerosis: A comprehensive reviewJournal of Autoimmunity, 2015
- Smoking and multiple sclerosis susceptibilityEuropean Journal of Epidemiology, 2013
- Genotyping Using the TaqMan AssayCurrent Protocols in Human Genetics, 2008
- Environmental risk factors for multiple sclerosis. Part I: The role of infectionAnnals of Neurology, 2007
- Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell culturesJournal of Neuroscience Research, 2001
- Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adultsVaccine, 1994